ProKidney Corp.

NASDAQ: PROK
Share price (12/20/24): $1.51
Market cap (12/20/24): $440 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

Suvretta Capital Management, LLC

News Filter

Material Definitive Agreement

Reports Third Quarter 2024 Financial Results Along With Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

Announces Strategic Updates to Its Phase 3 Program to Accelerate Rilparencel’s Registrational Path to Potential Approval in the U.S

Reports Business Updates and Second Quarter 2024 Financial Results

Announces Pricing of Its Upsized $130 Million Public Offering of Class a Ordinary Shares and Concurrent Registered Direct Offering

Proxies Filter

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness